The abundance of these HSPCs (including multipotent progenitors; CD7− CD38− CD34+ CD45RA− CD90−) in samples from patients with T-ALL were highly variable (supplemental Figure 1B-C). This evidence concerns the gene THY1 and acute lymphoblastic leukemia.